Literature DB >> 27716744

Mechanism of TAp73 inhibition by ΔNp63 and structural basis of p63/p73 hetero-tetramerization.

Jakob Gebel1, Laura M Luh1, Daniel Coutandin1, Christian Osterburg1, Frank Löhr1, Birgit Schäfer1, Ann-Sophie Frombach1, Manuela Sumyk1, Lena Buchner1, Tobias Krojer2, Eidarus Salah2, Sebastian Mathea2, Peter Güntert1, Stefan Knapp2,3, Volker Dötsch1.   

Abstract

Members of the p53 tumor-suppressor family are expressed as multiple isoforms. Isoforms with an N-terminal transactivation domain are transcriptionally active, while those ones lacking this domain often inhibit the transcriptional activity of other family members. In squamous cell carcinomas, the high expression level of ΔNp63α inhibits the tumor-suppressor function of TAp73β. This can in principle be due to blocking of the promoter or by direct interaction between both proteins. p63 and p73 can hetero-oligomerize through their tetramerization domains and a hetero-tetramer consisting of two p63 and two p73 molecules is thermodynamically more stable than both homo-tetramers. Here we show that cells expressing both p63 and p73 exist in mouse epidermis and hair follicle and that hetero-tetramer complexes can be detected by immunoprecipitation in differentiating keratinocytes. Through structure determination of the hetero-tetramer, we reveal why this hetero-tetramer is the thermodynamically preferred species. We have created mutants that exclusively form either hetero-tetramers or homo-tetramers, allowing to investigate the function of these p63/p73 hetero-tetramers. Using these tools, we show that inhibition of TAp73β in squamous cell carcinomas is due to promoter squelching and not direct interaction.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27716744      PMCID: PMC5136491          DOI: 10.1038/cdd.2016.83

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  33 in total

1.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.

Authors:  A Yang; R Schweitzer; D Sun; M Kaghad; N Walker; R T Bronson; C Tabin; A Sharpe; D Caput; C Crum; F McKeon
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

2.  p63 is a p53 homologue required for limb and epidermal morphogenesis.

Authors:  A A Mills; B Zheng; X J Wang; H Vogel; D R Roop; A Bradley
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

Review 3.  Force fields for protein simulations.

Authors:  Jay W Ponder; David A Case
Journal:  Adv Protein Chem       Date:  2003

4.  Structural evolution of p53, p63, and p73: implication for heterotetramer formation.

Authors:  Andreas C Joerger; Sridharan Rajagopalan; Eviatar Natan; Dmitry B Veprintsev; Carol V Robinson; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

5.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

Authors:  A Yang; M Kaghad; Y Wang; E Gillett; M D Fleming; V Dötsch; N C Andrews; D Caput; F McKeon
Journal:  Mol Cell       Date:  1998-09       Impact factor: 17.970

6.  Increased reliability of nuclear magnetic resonance protein structures by consensus structure bundles.

Authors:  Lena Buchner; Peter Güntert
Journal:  Structure       Date:  2015-01-08       Impact factor: 5.006

7.  Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63.

Authors:  J A McGrath; P H Duijf; V Doetsch; A D Irvine; R de Waal ; K R Vanmolkot; V Wessagowit; A Kelly; D J Atherton; W A Griffiths; S J Orlow; A van Haeringen; M G Ausems; A Yang; F McKeon; M A Bamshad; H G Brunner; B C Hamel; H van Bokhoven
Journal:  Hum Mol Genet       Date:  2001-02-01       Impact factor: 6.150

8.  p73 in Cancer.

Authors:  Alessandro Rufini; Massimiliano Agostini; Francesca Grespi; Richard Tomasini; Berna S Sayan; Maria Victoria Niklison-Chirou; Franco Conforti; Tania Velletri; Antonio Mastino; Tak W Mak; Gerry Melino; Richard A Knight
Journal:  Genes Cancer       Date:  2011-04

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  18 in total

1.  Sustained protein synthesis and reduced eEF2K levels in TAp73-\- mice brain: a possible compensatory mechanism.

Authors:  Barak Rotblat; Massimiliano Agostini; Maria Victoria Niklison-Chirou; Ivano Amelio; Anne E Willis; Gerry Melino
Journal:  Cell Cycle       Date:  2018-12-04       Impact factor: 4.534

Review 2.  Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine.

Authors:  Michele Carbone; Ivano Amelio; El Bachir Affar; James Brugarolas; Lisa A Cannon-Albright; Lewis C Cantley; Webster K Cavenee; Zhijian Chen; Carlo M Croce; Alan D' Andrea; David Gandara; Carlotta Giorgi; Wei Jia; Qing Lan; Tak Wah Mak; James L Manley; Katsuhiko Mikoshiba; Jose N Onuchic; Harvey I Pass; Paolo Pinton; Carol Prives; Nathaniel Rothman; Said M Sebti; James Turkson; Xifeng Wu; Haining Yang; Herbert Yu; Gerry Melino
Journal:  Cell Death Differ       Date:  2018-10-15       Impact factor: 15.828

3.  Designed Ankyrin Repeat Proteins as a tool box for analyzing p63.

Authors:  Alexander Strubel; Philipp Münick; Apirat Chaikuad; Birgit Dreier; Jonas Schaefer; Jakob Gebel; Christian Osterburg; Marcel Tuppi; Birgit Schäfer; Stefan Knapp; Andreas Plückthun; Volker Dötsch
Journal:  Cell Death Differ       Date:  2022-06-18       Impact factor: 15.828

Review 4.  p73 isoforms meet evolution of metastasis.

Authors:  Stella Logotheti; Athanasia Pavlopoulou; Stephan Marquardt; Işıl Takan; Alexandros G Georgakilas; Thorsten Stiewe
Journal:  Cancer Metastasis Rev       Date:  2022-08-11       Impact factor: 9.237

5.  ROCK-dependent phosphorylation of NUP62 regulates p63 nuclear transport and squamous cell carcinoma proliferation.

Authors:  Masaharu Hazawa; De-Chen Lin; Akiko Kobayashi; Yan-Yi Jiang; Liang Xu; Firli Rahmah Primula Dewi; Mahmoud Shaaban Mohamed; Mitsutoshi Nakada; Makiko Meguro-Horike; Shin-Ichi Horike; H Phillip Koeffler; Richard W Wong
Journal:  EMBO Rep       Date:  2017-12-07       Impact factor: 8.807

6.  Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK.

Authors:  Eric R Wolf; Ciarán P McAtarsney; Kristin E Bredhold; Amber M Kline; Lindsey D Mayo
Journal:  Sci Signal       Date:  2018-04-03       Impact factor: 8.192

7.  Integrin-β4 is a novel transcriptional target of TAp73.

Authors:  Ningxia Xie; Polina Vikhreva; Margherita Annicchiarico-Petruzzelli; Ivano Amelio; Nicolai Barlev; Richard A Knight; Gerry Melino
Journal:  Cell Cycle       Date:  2018-02-08       Impact factor: 4.534

8.  p73 Regulates Primary Cortical Neuron Metabolism: a Global Metabolic Profile.

Authors:  Massimiliano Agostini; Maria Victoria Niklison-Chirou; Margherita Maria Annicchiarico-Petruzzelli; Sandro Grelli; Nicola Di Daniele; Ilias Pestlikis; Richard A Knight; Gerry Melino; Alessandro Rufini
Journal:  Mol Neurobiol       Date:  2017-05-06       Impact factor: 5.590

Review 9.  Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism.

Authors:  Alice Nemajerova; Ivano Amelio; Jakob Gebel; Volker Dötsch; Gerry Melino; Ute M Moll
Journal:  Cell Death Differ       Date:  2017-10-27       Impact factor: 15.828

10.  Protein aggregation of the p63 transcription factor underlies severe skin fragility in AEC syndrome.

Authors:  Claudia Russo; Christian Osterburg; Anna Sirico; Dario Antonini; Raffaele Ambrosio; Julia Maren Würz; Jörg Rinnenthal; Marco Ferniani; Sebastian Kehrloesser; Birgit Schäfer; Peter Güntert; Satrajit Sinha; Volker Dötsch; Caterina Missero
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.